EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Decoding the urinary metabolome of aromatic amino acid pathways in Alport syndrome

Domniki Gallou, Jaime Morillas-Armenta, Miguel Fernández-García, Belen Requena, Santiago Angulo, Olga Begou, Helen Gika, Georgios Theodoridis, Gema Fernández-Juárez, Amir Shabaka, Ana Gradillas, Coral Barbas und 2 weitere

Analytical and Bioanalytical Chemistry · 2026

DOI: 10.1007/s00216-026-06707-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Domniki Gallou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Amino Acids, Aromatic, Metabolome, Nephritis, Hereditary. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Science and Innovation of Spain (MCIN), Red de Enfermedades Inflamatorias (REI), Talent Attraction Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) has been associated with alterations in plasma-free aromatic amino acids (AAA)-tryptophan (Trp), phenylalanine (Phe), and tyrosine (Tyr)-and some downstream metabolites. However, AAA metabolism comprises a wider set of compounds, including microbiome-derived and sulfate-conjugated metabolites excreted in urine with potential biological implications. Alport syndrome (AS), a genetic condition defined by progressive renal impairment, frequently advances to CKD, suggesting that disturbances in AAA-related metabolism may also be relevant in this disorder. Nevertheless, a comprehensive quantitative method covering AAA-derived metabolites enabling an assessment of their implications in AS has not been established. Here, we introduce a novel method for the quantification of up to 43 AAA-derived metabolites in urine, including sulfated metabolites. The method is based on liquid chromatography coupled to tandem mass spectrometry and includes six deuterated internal standards to achieve reliable quantitation. A pooled healthy urine sample was characterized, and the method was validated in terms of linearity, matrix effect, accuracy, precision and sensitivity. The method was applied to urine samples from AS patients-with CKD and non-CKD-and controls. Significant alterations across groups in the concentrations of metabolites from Trp, Phe, and Tyr pathways were observed, including 4-OH-phenylacetic acid-O-sulfate. Notably, the urinary kynurenic acid (KYNA)/Trp ratio emerged as a potential indicator of renal function, showing a marked increase in AS patients with CKD, consistent with enhanced kynurenine pathway activation. Overall, this analytical platform represents a valuable tool for clinical research and for advancing the understanding of AAA-related metabolic dysregulation in renal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acids, AromaticMetabolomeNephritis, HereditaryHumansTandem Mass SpectrometryMetabolomics

Stichwörter der Autor:innen

Aromatic amino acidsKidney diseaseMS/MS targeted metabolomicsMicrobial metabolitesSulfatome

Substanzen

Amino Acids, Aromatic

Autor:innen und Institutionen

  • Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Biomic AUTh, Center for Interdisciplinary Research and Innovation (CIRI-AUTH), Balkan Center B1.4, Thessaloniki, Greece.
  • Centro de Metabolómica y Bioanálisis (CEMBIO), Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain.
  • Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada "Nemesio Díez" (IMMA-ND), Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28860 Boadilla…
  • Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • ThetaBiomarkers, Balkan Center, Thessaloniki, Greece.

Förderung

  • Ministry of Science and Innovation of Spain (MCIN)
  • Red de Enfermedades Inflamatorias (REI)
  • Talent Attraction Grant
  • HORIZON-WIDERA-2021
  • San Pablo CEU Foundation

Zitieren

APA

Gallou, D., Morillas-Armenta, J., Fernández-García, M., Requena, B., Angulo, S., Begou, O., Gika, H., Theodoridis, G., Fernández-Juárez, G., Shabaka, A., Gradillas, A., Barbas, C., González-Ruiz, V., & Villaseñor, A. (2026). Decoding the urinary metabolome of aromatic amino acid pathways in Alport syndrome. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-026-06707-8

Vancouver

Gallou D, Morillas-Armenta J, Fernández-García M, Requena B, Angulo S, Begou O, et al. Decoding the urinary metabolome of aromatic amino acid pathways in Alport syndrome. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-026-06707-8

BibTeX
@article{Gallou2026,
  author = {Gallou, Domniki and Morillas-Armenta, Jaime and Fernández-García, Miguel and Requena, Belen and Angulo, Santiago and Begou, Olga and Gika, Helen and Theodoridis, Georgios and Fernández-Juárez, Gema and Shabaka, Amir and Gradillas, Ana and Barbas, Coral and González-Ruiz, Víctor and Villaseñor, Alma},
  title = {Decoding the urinary metabolome of aromatic amino acid pathways in Alport syndrome},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  doi = {10.1007/s00216-026-06707-8}
}
Kostenlos starten →